Optimal Translational Termination Requires C4 Lysyl Hydroxylation of eRF1

Molecular Cell

Volumn 53, Issue 4, 2014, Pages 645-654

  Feng, Tianshu ^a   Yamamoto, Atsushi ^a   Wilkins, Sarah E ^b   Sokolova, Elizaveta ^c   Yates, Luke A ^d   Münzel, Martin ^b   Singh, Pooja ^a   Hopkinson, Richard J ^b   Fischer, Roman ^a   Cockman, Matthew E ^a   Shelley, Jake ^a   Trudgian, David C ^e   Schödel, Johannes ^f   McCullagh, James S O ^b   Ge, Wei ^b   Kessler, Benedikt M ^a   Gilbert, Robert J ^d   Frolova, Ludmila Y ^c   Alkalaeva, Elena ^c   Ratcliffe, Peter J ^a   Schofield, Christopher J ^b   Coleman, Mathew L ^a,g   more..

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^f UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^g UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SEQUENCE; ANIMALS; CATALYSIS; CELL LINE, TUMOR; CODON, TERMINATOR; GENE EXPRESSION REGULATION; HELA CELLS; HISTONE DEMETHYLASES; HUMANS; HYDROLYSIS; HYDROXYLATION; MIXED FUNCTION OXYGENASES; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDE CHAIN TERMINATION, TRANSLATIONAL; PEPTIDE TERMINATION FACTORS; PROTEIN BIOSYNTHESIS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 84894247043     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2013.12.028     Document Type: Article

References (38)

1. Alkalaeva E.Z., Pisarev A.V., Frolova L.Y., Kisselev L.L., Pestova T.V. Invitro reconstitution of eukaryotic translation reveals cooperativity between release factors eRF1 and eRF3. Cell 2006, 125:1125-1136.
2. Bertram G., Bell H.A., Ritchie D.W., Fullerton G., Stansfield I. Terminating eukaryote translation: domain 1 of release factor eRF1 functions in stop codon recognition. RNA 2000, 6:1236-1247.
3. Bidou L., Allamand V., Rousset J.P., Namy O. Sense from nonsense: therapies for premature stop codon diseases. Trends Mol. Med. 2012, 18:679-688.
4. Chavatte L., Seit-Nebi A., Dubovaya V., Favre A. The invariant uridine of stop codons contacts the conserved NIKSR loop of human eRF1 in the ribosome. EMBO J. 2002, 21:5302-5311.
5. Coleman M.L., Ratcliffe P.J. Signalling cross talk of the HIF system: involvement of the FIH protein. Curr. Pharm. Des. 2009, 15:3904-3907.
6. Coleman M.L., McDonough M.A., Hewitson K.S., Coles C., Mecinovic J., Edelmann M., Cook K.M., Cockman M.E., Lancaster D.E., Kessler B.M., et al. Asparaginyl hydroxylation of the Notch ankyrin repeat domain by factor inhibiting hypoxia-inducible factor. J.Biol. Chem. 2007, 282:24027-24038.
7. Conard S.E., Buckley J., Dang M., Bedwell G.J., Carter R.L., Khass M., Bedwell D.M. Identification of eRF1 residues that play critical and complementary roles in stop codon recognition. RNA 2012, 18:1210-1221.
8. Fan-Minogue H., Du M., Pisarev A.V., Kallmeyer A.K., Salas-Marco J., Keeling K.M., Thompson S.R., Pestova T.V., Bedwell D.M. Distinct eRF3 requirements suggest alternate eRF1 conformations mediate peptide release during eukaryotic translation termination. Mol. Cell 2008, 30:599-609.
9. Frolova L., Seit-Nebi A., Kisselev L. Highly conserved NIKS tetrapeptide is functionally essential in eukaryotic translation termination factor eRF1. RNA 2002, 8:129-136.
10. Fu Y., Dai Q., Zhang W., Ren J., Pan T., He C. The AlkB domain of mammalian ABH8 catalyzes hydroxylation of 5-methoxycarbonylmethyluridine at the wobble position of tRNA. Angew. Chem. Int. Ed. Engl. 2010, 49:8885-8888.
11. Ge W., Wolf A., Feng T., Ho C.H., Sekirnik R., Zayer A., Granatino N., Cockman M.E., Loenarz C., Loik N.D., et al. Oxygenase-catalyzed ribosome hydroxylation occurs in prokaryotes and humans. Nat. Chem. Biol. 2012, 8:960-962.
12. Graille M., Figaro S., Kervestin S., Buckingham R.H., Liger D., Heurgué-Hamard V. Methylation of class I translation termination factors: structural and functional aspects. Biochimie 2012, 94:1533-1543.
13. Grentzmann G., Ingram J.A., Kelly P.J., Gesteland R.F., Atkins J.F. A dual-luciferase reporter system for studying recoding signals. RNA 1998, 4:479-486.
14. Holcik M., Graber T., Lewis S.M., Lefebvre C.A., Lacasse E., Baird S. Spurious splicing within the XIAP 5' UTR occurs in the Rluc/Fluc but not the betagal/CAT bicistronic reporter system. RNA 2005, 11:1605-1609.
15. Hon W.C., Wilson M.I., Harlos K., Claridge T.D., Schofield C.J., Pugh C.W., Maxwell P.H., Ratcliffe P.J., Stuart D.I., Jones E.Y. Structural basis for the recognition of hydroxyproline in HIF-1 alpha by pVHL. Nature 2002, 417:975-978.
16. Kaelin W.G., Ratcliffe P.J. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol. Cell 2008, 30:393-402.
17. Kallmeyer A.K., Keeling K.M., Bedwell D.M. Eukaryotic release factor 1 phosphorylation by CK2 protein kinase is dynamic but has little effect on the efficiency of translation termination in Saccharomyces cerevisiae. Eukaryot. Cell 2006, 5:1378-1387.
18. Kisselev L.L., Buckingham R.H. Translational termination comes of age. Trends Biochem. Sci. 2000, 25:561-566.
19. Kisselev L., Ehrenberg M., Frolova L. Termination of translation: interplay of mRNA, rRNAs and release factors?. EMBO J. 2003, 22:175-182.
20. Klose R.J., Kallin E.M., Zhang Y. JmjC-domain-containing proteins and histone demethylation. Nat. Rev. Genet. 2006, 7:715-727.
21. Kryuchkova P., Grishin A., Eliseev B., Karyagina A., Frolova L., Alkalaeva E. Two-step model of stop codon recognition by eukaryotic release factor eRF1. Nucleic Acids Res. 2013, 41:4573-4586.
22. Lemp N.A., Hiraoka K., Kasahara N., Logg C.R. Cryptic transcripts from a ubiquitous plasmid origin of replication confound tests for cis-regulatory function. Nucleic Acids Res. 2012, 40:7280-7290.
23. Loenarz C., Schofield C.J. Expanding chemical biology of 2-oxoglutarate oxygenases. Nat. Chem. Biol. 2008, 4:152-156.
24. Loenarz C., Schofield C.J. Physiological and biochemical aspects of hydroxylations and demethylations catalyzed by human 2-oxoglutarate oxygenases. Trends Biochem. Sci. 2011, 36:7-18.
25. Mantri M., Krojer T., Bagg E.A., Webby C.J., Butler D.S., Kochan G., Kavanagh K.L., Oppermann U., McDonough M.A., Schofield C.J. Crystal structure of the 2-oxoglutarate- and Fe(II)-dependent lysyl hydroxylase JMJD6. J.Mol. Biol. 2010, 401:211-222.
26. Nakamura Y., Ito K. tRNA mimicry in translation termination and beyond. Wiley Interdiscip Rev RNA 2011, 2:647-668.
27. Noma A., Ishitani R., Kato M., Nagao A., Nureki O., Suzuki T. Expanding role of the jumonji C domain as an RNA hydroxylase. J.Biol. Chem. 2010, 285:34503-34507.
28. Polshakov V.I., Eliseev B.D., Birdsall B., Frolova L.Y. Structure and dynamics in solution of the stop codon decoding N-terminal domain of the human polypeptide chain release factor eRF1. Protein Sci. 2012, 21:896-903.
29. Shoemaker C.J., Green R. Kinetic analysis reveals the ordered coupling of translation termination and ribosome recycling in yeast. Proc. Natl. Acad. Sci. USA 2011, 108:E1392-E1398.
30. Song H., Mugnier P., Das A.K., Webb H.M., Evans D.R., Tuite M.F., Hemmings B.A., Barford D. The crystal structure of human eukaryotic release factor eRF1-mechanism of stop codon recognition and peptidyl-tRNA hydrolysis. Cell 2000, 100:311-321.
31. Steneberg P., Englund C., Kronhamn J., Weaver T.A., Samakovlis C. Translational readthrough in the hdc mRNA generates a novel branching inhibitor in the Drosophila trachea. Genes Dev. 1998, 12:956-967.
32. Taylor D., Unbehaun A., Li W., Das S., Lei J., Liao H.Y., Grassucci R.A., Pestova T.V., Frank J. Cryo-EM structure of the mammalian eukaryotic release factor eRF1-eRF3-associated termination complex. Proc. Natl. Acad. Sci. USA 2012, 109:18413-18418.
33. Tian Y.M., Yeoh K.K., Lee M.K., Eriksson T., Kessler B.M., Kramer H.B., Edelmann M.J., Willam C., Pugh C.W., Schofield C.J., Ratcliffe P.J. Differential sensitivity of hypoxia inducible factor hydroxylation sites to hypoxia and hydroxylase inhibitors. J.Biol. Chem. 2011, 286:13041-13051.
34. Unoki M., Masuda A., Dohmae N., Arita K., Yoshimatsu M., Iwai Y., Fukui Y., Ueda K., Hamamoto R., Shirakawa M., et al. Lysyl 5-hydroxylation, a novel histone modification, by Jumonji domain containing 6 (JMJD6). J.Biol. Chem. 2013, 288:6053-6062.
35. van den Born E., Vågbø C.B., Songe-Møller L., Leihne V., Lien G.F., Leszczynska G., Malkiewicz A., Krokan H.E., Kirpekar F., Klungland A., Falnes P.Ø. ALKBH8-mediated formation of a novel diastereomeric pair of wobble nucleosides in mammalian tRNA. Nat Commun 2011, 2:172.
36. Walsh C.T. Posttranslational Modification of Proteins: Expanding Nature's Inventory 2005, Roberts and Company Publishers, Greenwood Village.
37. Webby C.J., Wolf A., Gromak N., Dreger M., Kramer H., Kessler B., Nielsen M.L., Schmitz C., Butler D.S., Yates J.R., et al. Jmjd6 catalyses lysyl-hydroxylation of U2AF65, a protein associated with RNA splicing. Science 2009, 325:90-93.
38. Yamaguchi Y., Hayashi A., Campagnoni C.W., Kimura A., Inuzuka T., Baba H. L-MPZ, a novel isoform of myelin P0, is produced by stop codon readthrough. J.Biol. Chem. 2012, 287:17765-17776.